In contrast, ViroTreat assesses inversion of the virus-induced MR activity signature by assessing the enrichment of the 25 most activated and 25 most inactivated viral infection MRs in proteins differentially inhibited and activated in drug versus vehicle control–treated cells, respectively. The gene discussed is NR3C2; the disease is viral infectious disease.